A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the Blood
1 other identifier
interventional
300
1 country
1
Brief Summary
IgG4 Related Disease is a multi-systemic fibroenophilic disease that includes a basket of recently discovered medical conditions. The properties that bind them are: lesions similar to tumors in the mixed organs, lymphoplasms filtrate enriched with plasma IgG4 positive cells, storiform fibrosis, and often, but not always, a high level of IgG4 in the serum. This disease has been on the rise for the past two decades and since its recognition in 2001 there has been impressive progress in understanding its various manifestations, so that today almost every body system can be involved. One of the conditions associated with this disease is oritis / periortitis and aneurysms
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2017
CompletedFirst Posted
Study publicly available on registry
August 30, 2017
CompletedStudy Start
First participant enrolled
November 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedNovember 9, 2017
August 1, 2017
11 months
August 29, 2017
November 8, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
IgG4 Level
count IgG4 Level to figure if its IgG4-related disease
1 year
Study Arms (1)
single arm
EXPERIMENTALPatients after aneurysm in the aorta, Men and women aged 18-100 (not including special populations), who are able to read understand and sign a written consent to participate in the research
Interventions
Eligibility Criteria
You may qualify if:
- Patients after aneurysm in the aorta
- Men and women aged 18-100 (not including special populations)
- Those who are able to read understand and sign a written consent to participate in the research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yael Eizikovits
Kfar Saba, 44281, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yael Eizikovits, B.A
Meir Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 29, 2017
First Posted
August 30, 2017
Study Start
November 8, 2017
Primary Completion
October 1, 2018
Study Completion
October 1, 2018
Last Updated
November 9, 2017
Record last verified: 2017-08